Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

83 filings reported holding PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22.9M shares of 62.9M outstanding shares and own 36.43% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (4.18M shares), Laurion Capital Management LP (3.86M shares), Balyasny Asset Management L.P. (2.59M shares), STEMPOINT CAPITAL LP (1.79M shares), Ikarian Capital, LLC (1.66M shares), VANGUARD GROUP INC (1.4M shares), abrdn plc (708K shares), MILLENNIUM MANAGEMENT LLC (583K shares), SUPERSTRING CAPITAL MANAGEMENT LP (494K shares), and BOOTHBAY FUND MANAGEMENT, LLC (492K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.